Key result
Severely reduced LVEF linked to ~139% greater 5-year mortality after isolated CABG versus normal LVEF.
Why the study?
Pre-operative ejection fraction and comorbidities affect post-operative outcomes, but their relative impact on mortality and adverse events across baseline ejection fraction strata needed evaluation.
Does pre-operative left ventricular ejection fraction affect mid-term mortality and cerebro-cardiovascular events in patients undergoing isolated CABG?
Cohort (n=20,937)
No
Does pre-operative left ventricular ejection fraction affect mid-term mortality and cerebro-cardiovascular events in patients undergoing isolated CABG?
Severely reduced pre-operative LVEF (<35%) is associated with significantly higher mid-term all-cause mortality after isolated CABG compared to higher EF levels, though the rate of non-fatal cerebro-cardiovascular events is not significantly increased.
BACKGROUND: Pre-operative ejection fraction (EF) and comorbidities affect post-op outcomes. We aimed to compare the mortality and adverse events of patients with different baseline EF and also to evaluate the distribution of comorbidities in each EF group. METHODS: A total of 20,937 patients who underwent isolated coronary artery bypass graft (CABG) surgery from January 2006 to December 2016 was included. Patients were divided into three groups based on their pre-operative left ventricular EF as follows; (1) Normal: EF ≥ 50%; (2) Mild to moderately reduced: 50% < EF ≤ 35%; and (3) Severely reduced: EF < 35%. The backward elimination method was considered for multivariate Cox-regression analysis to locate predictors of mortality and non-fatal cerebro-cardiovascular events (CCVEs). The median follow-up time was 5.61 [3.12-8.0] years. RESULTS: The mean age in the total population was 60.94 ± 9.51 years and 73.6% of the total population was male. Diabetes mellitus was the common risk factor of mortality and CCVE in all EF groups. Impaired renal function (GFR < 60 ml/min) was associated with a higher risk of mortality after CABG regardless of EF level. The median 5-year mortality rate in patients with normal EF, mild-moderately reduced EF and severely reduced EF were 9.5%, 12.8%, and 22.7% respectively (P < 0.001). Although the trend of CCVEs was higher in severe left ventricle (LV) dysfunction, it was not statistically significant (p = 0.071). CONCLUSION: Patients with severely reduced EF are at higher risk of mortality after CABG compared to those with higher EF levels; however, the rate of CCVEs may not be necessarily higher after adjustment for multiple pre-operative comorbidities.
No takes yet. Share an insight, caveat, or question.
Fallahzadeh et al. (2021) conducted a cohort in Ischemic heart disease (n=20,937). Severely reduced ejection fraction (EF < 35%) vs. Normal ejection fraction (EF ≥ 50%) was evaluated on 5-year all-cause mortality (p=<0.001). Patients with severely reduced ejection fraction (<35%) had a significantly higher 5-year mortality rate of 22.7% after isolated CABG compared to 9.5% in patients with normal ejection fraction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: